Therapy with tumor necrosis factor inhibitors, nonsteroidal antiinflammatory drugs, ustekinumab in early stages of osteitis may halt molecular switching to bone-forming phenotype characteristic of SpA
Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium
By regulating molecules key to osteoclast/osteoblast processes, methotrexate may reduce bone destruction in inflammatory arthritis, osteolysis, especially in combination with adenosine
ACR Board of Directors Tackles Slate of Business at Annual Meeting
Board welcomes 233 new and returning candidates, lends support to lupus classification criteria in partnership with EULAR, approves update of ACR policy statements and position statements at February meeting in Napa, Calif.
Research Into Causes of Systemic Vasculitis May Lead to Targeted Treatments Say Rheumatologists at the 2013 ACR/ARHP Annual Meeting
Studies focused on role of the immune system in disease development, and contributing genetic and environmental factors, may elicit better therapeutic approaches to small- and large-vessel vasculitis
Switches That Regulate Gene Expression Offer Better Understanding of Rheumatic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting
New studies examine why turning on or off switches in genes that control the genome can contribute to pathogenesis of such autoimmune diseases as systemic lupus erythematosus or rheumatoid arthritis
Causes of Alopecia Can Vary Among Patients with Systemic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting
Beyond such autoimmune diseases as systemic lupus erythematosus and rheumatoid arthritis, rheumatologists should consider hypothyroidism, dietary issues, and grooming habits in patients with hair loss
Evolutionary Medicine Provides Insight into the Chronic Inflammatory State Note Rheumatologists at the 2013 ACR/ARHP Annual Meeting
Studies on metabolism, neuroendocrinology, and immunology can broaden understanding of the pathophysiology of chronic inflammatory diseases
Research Reveals Clues Into Inflammatory Process of Crystal Arthropathies Note Experts at the 2013 ACR/ARHP Annual Meeting
New studies clarify the roles of monosodium urate crystals in gout, calcium pyrophosphate crystals in osteoarthritis, and identify more effective potential therapies for patients
Do Women Receive Worse Gout Treatment Than Men?
Women with gout are more likely to have contraindications to nonsteroidal antiinflammatory drugs and are less likely to receive urate-lowering drugs than men with the disease. (posted Feb. 5)
2013 ACR/ARHP Annual Meeting: Strides Made in Understanding Systemic Sclerosis
Greater knowledge of how vasculitis, fibrosis, and autoimmunity interact in these destructive diseases will result in better clinical management
- « Previous Page
- 1
- …
- 81
- 82
- 83
- 84
- 85
- …
- 98
- Next Page »